Hallucination

Among young adults aged 19 to 30 years and early midlife adults aged 35 to 50 years, past-year use of cannabis and hallucinogens remained at “historically high” levels in 2023, according to the Monitoring the Future Panel Study Annual Report.

NEW YORK — One dose of lysergide produced clinical remission of generalized anxiety disorder as soon as 4 weeks after treatment, according to a study presented at the American Psychiatric Association annual meeting.

Artificial intelligence performed better at clinical reasoning and processing medical data compared with internal medicine residents and attending physicians, a study in JAMA Internal Medicine showed.

A psilocybin formulation was well tolerated among healthy patients, which supports research into its use for treatment-resistant depression, according to data presented at the American Society of Clinical Psychopharmacology Annual Meeting.

Early improvements of individual symptoms might contribute to later treatment response among patients with Alzheimer’s disease receiving antipsychotics for neuropsychiatric symptoms, according to findings of a re-analysis study published in Journal of Clinical Psychiatry.

Results of a randomized clinical trial demonstrated a favorable safety profile and efficacy of lumateperone for patients with schizophrenia.

Findings published in npj Schizophrenia have shed light on the brain mechanisms associated with auditory hallucinations among patients with schizophrenia. Primarily, altered tonotopic organization of the auditory cortex plays a prominent role in this phenomenon, and alteration may occur during infancy, researchers reported.